Insight

Oct 10, 2024, 15:57

New ESMO Open editorial on Immunotherapy in breast cancer

ESMO Open shared a recent article by Paola Zagami on X:

“Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?”

Dario Trapani shared a post on X:

“Don’t miss the new ESMO Open editorial on Immunotherapy in breast cancer.”

Title: Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?

Authors: P. Zagami, J. Cortés, L.A. Carey and G. Curigliano.

New ESMO Open editorial on Immunotherapy in breast cancer

Source: ESMO Open/X and Dario Trapani/X

Dario Trapani is a medical oncologist at the European Institute of Oncology (IEO) and a researcher in the Department of Oncology and Hemato-oncology at the University of Milan. He previously served as a Postdoctoral Researcher at the Dana-Farber Cancer Institute and is focused on population health research.

Breast Cancer cancer Dario Trapani ESMO Open European Institute of Oncology G Curigliano immunotherapy J. Cortes L.A. Carey OncoDaily Oncology P. Zagami University of Milan

Aladina Foundation was Honored with the Yvonne Humanitarian Award by OncoDaily

Rod Stewart and Prostate Cancer: How He Went Against, How He Survived, and More

Kimryn Rathmell: The year in cancer - 24 advances in 2024

Celebrating the Holiday Magic with Medical Community

Melanie Griffith and Skin Cancer: How She Went Against, How She Survived, and More

Special Coverage